Gradient Investments LLC Decreases Stock Holdings in The Cooper Companies, Inc. $COO

Gradient Investments LLC lowered its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 22.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,829 shares of the medical device company’s stock after selling 9,102 shares during the period. Gradient Investments LLC’s holdings in Cooper Companies were worth $2,282,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of COO. State Street Corp raised its stake in Cooper Companies by 2.4% in the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after buying an additional 207,195 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after acquiring an additional 2,231,568 shares in the last quarter. Sustainable Growth Advisers LP boosted its position in shares of Cooper Companies by 22.1% during the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after acquiring an additional 747,476 shares in the last quarter. Finally, Franklin Resources Inc. increased its holdings in shares of Cooper Companies by 108.2% in the 4th quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock valued at $329,646,000 after acquiring an additional 2,089,763 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO stock opened at $74.23 on Monday. The stock’s 50-day moving average is $69.64 and its two-hundred day moving average is $71.44. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The firm has a market cap of $14.48 billion, a price-to-earnings ratio of 62.91, a PEG ratio of 1.94 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on COO. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. UBS Group initiated coverage on Cooper Companies in a report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 price target for the company. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Stifel Nicolaus cut their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Friday, June 5th. Finally, Robert W. Baird reduced their price objective on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Hold” and a consensus price target of $81.36.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.